Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Trading Update

20 Jul 2016 07:00

RNS Number : 6713E
HydroDec Group plc
20 July 2016
 

20 July 2016

 

Hydrodec Group plc

("Hydrodec", the "Company" or the "Group")

 

Trading Update

 

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group is pleased to provide a trading update in respect of the six month period ended 30 June 2016.

 

Highlights

· Increased Group sales volumes of premium quality SUPERFINE transformer oil and base oil in H1 of 16.75 million litres (H1 2015: 1.7 million litres), reflecting full commissioning of new Canton plant at the end of 2015 - record monthly sales in June of 3.2m litres

· Improving plant utilisation - Canton reaching 76% in May

· Continued successful production in Australia and improving feedstock position

· Revenues from continuing core re-refining business for H1 2016 expected to increase by approximately 130% to US$7.6 million (H1 2015: US$3.3 million)

· H1 2016 gross unit margins in continuing business higher than H1 2015 despite lower product sales prices and challenging market conditions

· Disposal of loss-making UK recycling operations in March

 

Update

 

The Board is pleased to report significant progress in delivering the Company's key objectives since the beginning of the year.

 

The main drivers in 2016 have been to refocus on the core transformer oil re-refining technology by optimising the performance of the Canton facility, and to increase production levels through a combination of leveraging the experience gained since fully commissioning the plant at the end of last year along with specific targeted operating improvements. These improvements have been validated by the significantly lower number of production hours lost through unscheduled stoppages and the record monthly production performance of the plant in May of 2.82 million litres of SUPERFINE transformer oil and base oil.

 

An additional primary objective relates to improving the sales mix between higher margin transformer oil and lower margin base oil produced at the Canton plant. At the beginning of the year, January transformer oil sales represented 19% of US volumes sold. Since then significant improvements have been made in this area and in June transformer oil represented 71% of sales, with further advances expected.

 

In respect of the operations in Australia, since the commissioning of the plant at the Southern Oil Refinery in May 2015 we have had to work extremely hard to re-establish our commercial position in the market. I am pleased to report that in May, the Australian business enjoyed one of its highest feedstock acquisition months since 2012 and the underlying pipeline continues to grow steadily.

 

Finally, there has been a key focus on the reduction of corporate costs. Significant reductions have already been realised with the expectation that the benefits from more recently implemented initiatives will filter through in H2.

 

Given that the Group's key operations are in the US and Australia, the Board does not expect there to be any material impact on the Group's performance as a result of the Brexit referendum.

 

Outlook

 

In summary, the information provided today confirms significant progress in the turnaround of the Company over the first half of the year. Our key objective during the rest of the year is to strengthen margins as we grow market share whilst continuing the program of cost reduction. We continue to make strong progress towards positive Group EBITDA in the second half of the year.

 

Chris Ellis, Chief Executive Officer of Hydrodec, commented: "I am pleased to be able to report significant progress in moving Hydrodec towards profitability and expanding its position in the transformer oil market in our key operating arenas. Whilst market conditions remain challenging, we are focused on delivering our operational plans and also primed to take advantage of the opportunities the current market may yet present to grow the business both in our existing areas of focus and in new markets."

 

For further information please contact:

 

Hydrodec Group plc

 

020 3300 1643

Chris Ellis, Chief Executive

Mike Preen, Company Secretary

 

 

 

Canaccord Genuity (Nominated Adviser and Broker)

 

020 7418 8900

Guy Marks

Henry Fitgerald-O'Connor

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7016 9570

Patrick d'Ancona

Chris McMahon

 

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. MarketsandMarkets forecasts that the global transformer oil market is expected to grow from US$1.98 billion in 2015 to US$2.79 billion by 2020 at a CAGR of 7.14% from 2015 to 2020. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US and Bomen, New South Wales, Australia. 

 

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKCDNDBKBPOD
Date   Source Headline
7th Apr 20117:00 amRNSFinal Results
8th Mar 201111:22 amRNSNotice of Results
24th Jan 20117:00 amRNSNotification of Interest
17th Jan 20111:03 pmRNSDirector's dealing in securities
5th Jan 20113:17 pmRNSNotification of Interest
2nd Dec 20107:00 amRNSTrading Update
9th Nov 201012:19 pmRNSNotification of Interest
1st Nov 201010:59 amRNSNotification of Interest
29th Oct 20104:12 pmRNSTotal Voting Rights
25th Oct 201010:56 amRNSLoan Note Conversion Price Adjustment
25th Oct 201010:56 amRNSLoan Note Conversion Price Adjustment
21st Oct 201011:43 amRNSNotification of Interest
21st Oct 201011:43 amRNSNotification of Interest
19th Oct 20104:41 pmRNSNotification of Interest
14th Oct 201010:36 amRNSResult of General Meeting
8th Oct 20105:13 pmRNSNotification of Interest
4th Oct 20104:16 pmRNSNotification of Interest
24th Sep 20104:27 pmRNSPosting of Circular
24th Sep 201011:35 amRNSPlacement of Ordinary Shares
31st Aug 20107:00 amRNSUnaudited Interim Results
25th Aug 201010:00 amRNSNotice of Results
19th Jul 20107:00 amRNSTrading Update
9th Jul 20104:27 pmRNSNotification of Interest
9th Jul 201010:18 amRNSNotification of Interest
5th Jul 20101:33 pmRNSNotification of Interest
2nd Jul 201011:24 amRNSDirector's Dealing
8th Jun 20109:34 amRNSLoan Note Conversion Price Adjustment
27th May 201011:42 amRNSResult of AGM
27th May 20107:00 amRNSAGM Statement and Trading Update
6th May 20101:14 pmRNSNotification of Interest
5th May 201011:14 amRNSAnnual Report and Notice of AGM
4th May 201010:06 amRNSTotal Voting Rights
29th Apr 20102:45 pmRNSNOTIFICATION OF INTEREST IN SHARES
28th Apr 20107:00 amRNSFinal Results
22nd Apr 20102:45 pmRNSNotice of Results
13th Apr 201010:35 amRNSResult of General Meeting
31st Mar 20105:35 pmRNSNotification of Interest
31st Mar 201011:06 amRNSTotal Voting Rights
26th Mar 20104:00 pmRNSPosting of Circular
23rd Mar 20107:00 amRNSPlacement of Ordinary Shares
19th Mar 20107:00 amRNSPotential fund raising and strategic investment
4th Mar 20107:00 amRNSJapanese Strategic Alliance Agreement
1st Feb 201012:18 pmRNSTotal Voting Rights
15th Jan 20109:14 amRNSTrading Update
13th Jan 201010:29 amRNSJapanese Approval of Technology
12th Jan 20102:50 pmRNSDirector's Dealing in Securtiities
7th Jan 201011:44 amRNSResult of Meeting
31st Dec 20097:00 amRNSTotal Voting Rights
23rd Dec 20091:39 pmRNSNotification of Major Interest in Shares
16th Dec 20097:00 amRNSPosting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.